MedPath

Mandibular Advancement Device (MAD) therapy in edentulous patients with obstructive sleep apnea: dental implant fixed MADs vs. CPAP.

Withdrawn
Conditions
Obstructive sleep apnea syndrome
sleep apnea
10046304
10019190
Registration Number
NL-OMON45006
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
38
Inclusion Criteria

- Male of female
- Age 18 * 75 years
- Sufficient understanding of Dutch language in speaking and writing.
- Completely (mandibular and maxillary) edentate with or without dental implants
- Diagnosed with mild or moderate OSA (AHI between 5 * 30)
- No previous OSA therapy

Exclusion Criteria

- Craniofacial deformities
- Medication use related to a sleeping disorder
- Evidence of respiratory/sleep disorders other than OSA (eg. central sleep apnea syndrome).
- Reversible morphological upper airway abnormalities (e.g. enlarged tonsils).
- Temporomandibular disorders
- Intravenous bisphosphonates therapy (osteoporosis).
- Previous radiotherapy in head and/or neck area

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>AHI (baseline vs. 3 months): apnea hypopnea Index (AHI) derived from<br /><br>standardized polysomnography studies at baseline and 3 months after CPAP<br /><br>treatment initiation (control-group) or MAD therapy initiation (intervention<br /><br>group). </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath